Watson recalls one batch of fentanyl patches

08/11/2008 | FDAnews

Watson Pharmaceuticals has voluntarily recalled one batch of its fentanyl transdermal system patches in the U.S. after finding a limited number of leaks that may cause serious side effects such as respiratory depression. Watson said it has informed the FDA and does not expect any product shortages because of the recall.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX